Abstract:Chronic obstructive pulmonary disease is a severe lung disease characterized by tissue destruction and limited airflow mainly caused by exposure to harmful environmental substances. Primary symptoms of this lung disorder include dyspnea, sputum production, and cough, which leads to respiratory failure. Prevalence increases with age, making it the most common cause of death worldwide. The primary objective of this study was to identify novel therapeutic targets via gene expression meta-analysis and to utilize them for drug reprofiling of FDA-approved drugs in treating chronic obstructive pulmonary disease. Multiple microarray and RNA-seq datasets from alveolar macrophages comprising healthy and diseased patients were processed to pinpoint significant dysregulated genes involved in this disease. Next, a meta-analysis was performed to identify the consistently differentially expressed genes in all datasets. Functional enrichment and protein-protein interaction analyses were conducted to single out the hub genes. Moreover, 3D structure prediction, virtual screening, and molecular dynamics simulations were utilized to explore the selected hub gene for drug repurposing. The number of significantly dysregulated genes identified via RNA-seq and microarray meta-analysis was found to be 104 and 57, respectively. Interestingly, VGLL3, ITIH5, ELOVL7, ACOD1, LAMB1, CXCL9, and GBP5 were common between the two sets revealing their significant association with the disease. CXCL9 and CCL3L3 were identified as the common hub genes between both sets. However, CXCL9, a chemokine, was prioritized for drug repurposing endeavors as it exhibits remarkable involvement in immune response and inflammation. Virtual screening of CXCL9 against selected drugs disclosed that CXCL9 has the highest binding affinity of −7.3 kcal/mol for Nintedanib, and binding affinities ranged from −2.4 kcal/mol to −7.3 kcal/mol. Moreover, Tepotinib and Crizotinib were found to be the second and third top-scoring drugs of −6.8 kcal/mol and −6.2 kcal/mol, respectively. Furthermore, the molecular dynamics simulation revealed that Crizotinib showed the most prominent results; however, its binding affinity is lower than Nintedanib. Therefore, Nintedanib is suggested as the better therapeutic agent to inhibit CXCL9 for treating chronic obstructive pulmonary disease.

Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model

COPD lung studies of Nrf2 expression and the effects of Nrf2 activators

Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis

Nrf2/HO-1 signaling activation alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease by suppressing NLRP3-mediated pyroptosis

Targeting Immunoproteasome in Polarized Macrophages Ameliorates Experimental Emphysema Via Activating NRF1/2-P62 Axis and Suppressing IRF4 Transcription

Deficiency of the Transcription Factor NR4A1 Enhances Bacterial Clearance and Prevents Lung Injury During Escherichia Coli Pneumonia

Bacterial Colonization Dampens Influenza-Mediated Acute Lung Injury Via Induction of M2 Alveolar Macrophages

Transcriptomic Profiling Identifies a Critical Role of Nrf2 in Regulating the Inflammatory Response to Fly Ash Particles in Mouse Lung

A Low Expression of NRF2 Enhances Oxidative Stress and Autophagy in Myofibroblasts, Promoting Progression of Chronic Obstructive Pulmonary Disease

Exploring Inflammatory Dysregulation in Alveolar Macrophages: Implications for Novel Therapeutic Targets in Chronic Obstructive Pulmonary Disease

Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously

[Advances in Research on the Role of Alveolar Macrophage Burial Function in Chronic Obstructive Pulmonary Disease].

Single-Cell Sequencing of Lung Macrophages and Monocytes Reveals Novel Therapeutic Targets in COPD

Down-regulation of RTEL1 Improves M1/M2 Macrophage Polarization by Promoting SFRP2 in Fibroblasts-derived Exosomes to Alleviate COPD

[The Expressions of Nerve Growth Factor and Its Tyrosine Kinase A Receptor on Alveolar Macrophages in a Rat Model of Chronic Obstructive Pulmonary Disease].

CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and Cystic Fibrosis mice

Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages

Commensal Microbiota Maintains Alveolar Macrophages with A Low Level of Ccl24 Production to Generate Anti-Metastatic Tumor Activity

Codonopsis Radix Inhibits the Inflammatory Response and Oxidative Stress in Chronic Obstructive Pulmonary Disease Mice through Regulation of the Nrf2/NF-κB Signaling Pathway

Activation of Nrf2 modulates protective immunity against Mycobacterium tuberculosis infection in THP1-derived macrophages

Macrophage specific restoration of the Nrf2 gene in whole-body knockout mice ameliorates steatohepatitis induced by lipopolysaccharide from Porphyromonas gingivalis through enhanced hepatic clearance